Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 4471 to 4485 of 8322 results

  1. What is the optimal method for assessing tinnitus in general practice (including consultation questions, physical examinations and questionnaires)?

    Recommendation ID NG155/3 Question What is the optimal method for assessing tinnitus in general practice (including consultation questions

    Research recommendation
    Published
    17 March 2020

  2. What is the clinical and cost effectiveness of a combination management strategy consisting of sound therapy and tinnitus support?

    Recommendation ID NG155/2 Question What is the clinical and cost effectiveness of a combination management strategy consisting of sound

    Research recommendation
    Published
    17 March 2020

  3. What is the clinical and cost effectiveness of cognitive behavioural therapy (CBT) for adults with tinnitus delivered by appropriately trained healthcare professionals other than psychologists (for example, audiologists)?

    Recommendation ID NG155/1 Question What is the clinical and cost effectiveness of cognitive behavioural therapy (CBT) for adults with tinnitus

    Research recommendation
    Published
    17 March 2020

  4. What is the clinical and cost effectiveness of amplification devices for people who are d/Deaf or who have a severe-to-profound hearing loss?

    Recommendation ID NG155/10 Question What is the clinical and cost effectiveness of amplification devices for people who are d/Deaf or who

    Research recommendation
    Published
    17 March 2020

  5. What is the clinical and cost effectiveness of psychological therapies for people who are d/Deaf or who have a severe-to-profound hearing loss and tinnitus-related distress?

    Recommendation ID NG155/11 Question What is the clinical and cost effectiveness of psychological therapies for people who are d/Deaf or

    Research recommendation
    Published
    17 March 2020

  6. Imaging options in occult hip fracture: In people with a continuing suspicion of a hip fracture but whose radiographs are normal, what is the clinical and cost effectiveness of CT compared with MRI, in confirming or excluding the fracture?

    Recommendation ID CG124/01 Question Imaging options in occult hip fracture: In people with a continuing suspicion of a hip fracture but

    Research recommendation
    Published
    3 February 2023

  7. Thiazide: In people with acute heart failure and persistent congestion, does the addition of a thiazide diuretic to standard therapy lead to greater diuresis compared with adding placebo to standard therapy?

    Recommendation ID CG187/02 Question Thiazide: In people with acute heart failure and persistent congestion, does the addition of a thiazide

    Research recommendation
    Published
    16 December 2021

  8. Dopamine: In people with acute heart failure, congestion and worsening renal function, does the addition of low‑dose dopamine to standard therapy lead to greater diuresis and renal protection compared with adding placebo to standard therapy?

    Recommendation ID CG187/01 Question Dopamine: In people with acute heart failure, congestion and worsening renal function, does the addition

    Research recommendation
    Published
    16 December 2021

  9. Diuretic therapy for managing fluid overload in people with advanced heart failure in the community:-  In people with advanced heart failure and significant peripheral fluid overload, what is the clinical and cost effectiveness of oral, subcutaneous and intravenous diuretic therapy in the community?

    Recommendation ID NG106/1 Question Diuretic therapy for managing fluid overload in people with advanced heart failure in the community:-

    Research recommendation
    Published
    17 December 2018

  10. Mucolytic therapy:- In people with COPD, does mucolytic drug therapy prevent exacerbations in comparison with placebo and other therapies?

    Recommendation ID NG115/11 Question Mucolytic therapy:- In people with COPD, does mucolytic drug therapy prevent exacerbations in comparison

    Research recommendation
    Published
    13 February 2019

  11. Ultrafiltration: In people with decompensated heart failure, fluid congestion and diuretic resistance, does ultrafiltration lead to more rapid and effective decongestion compared with continuing diuretic treatment?

    Recommendation ID CG187/04 Question Ultrafiltration: In people with decompensated heart failure, fluid congestion and diuretic resistance

    Research recommendation
    Published
    16 December 2021

  12. In people with high-risk non-muscle-invasive bladder cancer, are these follow-up regimens equally effective in terms of identification of progression, cost effectiveness and health-related quality of life? - Cystoscopic follow-up at 3, 6, 12, 18, 24, 36 and 48 months, and then annually, interspersed with non-invasive urinary tests. - Cystoscopic follow-up at 3, 6, 9, 12, 15, 18, 21, 24, 30, 36, 42 and 48 months, and then annually thereafter.

    Recommendation ID NG2/3 Question In people with high-risk non-muscle-invasive bladder cancer, are these follow-up regimens equally effective

    Research recommendation
    Published
    9 June 2015

  13. Vitamin D supplements in the management of CKD–mineral and bone disorders: In people with hyperparathyroidism secondary to CKD, does treatment with vitamin D or vitamin D analogues improve patient-related outcomes?

    Recommendation ID NG203/21 Question Vitamin D supplements in the management of CKD–mineral and bone disorders: In people with hyperparathyroidism

    Research recommendation
    Published
    30 September 2021

  14. Techniques for confirming a diagnosis in people with suspected atypical Spitzoid melanocytic lesions: In people with reported atypical Spitzoid lesions, how effective are fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH) and tests to detect driver mutations compared with histopathological examination alone in predicting disease specific survival? This should be investigated ina prospective diagnostic study. Secondary outcomes should include sensitivity, specificity, accuracy, positive predictive value, disease specific survival and progression free survival.

    Recommendation ID NG14/07 Question Techniques for confirming a diagnosis in people with suspected atypical Spitzoid melanocytic lesions:

    Research recommendation
    Published
    4 August 2022

  15. Vitamin D supplementation: In people with stage I to III melanoma does vitamin D supplementation improve overall survival? This should be investigated in a placebo controlled randomised trial. Secondary outcomes should include disease specific survival and toxicity, including the development of renal stones and hypercalcaemia.

    Recommendation ID NG14/09 Question Vitamin D supplementation: In people with stage I to III melanoma does vitamin D supplementation improve

    Research recommendation
    Published
    4 August 2022